ACTRN12607000489493招募中未知
The Asthma Feedback Study - The impact of providing feedback onadherence in childhood asthma.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 6 Years 至 15 Years（—）
- 性别
- All
入选标准
- •Aged 6 - 15 years, frequent episodic or chronic persistent asthma, taking daily preventive inhaled corticosteroid medication.
排除标准
- •Other underlying lung disorder, not taking inhaled corticosteroid medication.
研究者
相似试验
招募中
1 期
A study to assess the effect allergic rhinitis in a non asthmatic individual on the lung functionsCTRI/2019/01/016940il
进行中（未招募）
1 期
Study to compare the effectiveness of Salmeterol/Fluticasone Propionate to Montelukast in treating asthma is children.AsthmaEUCTR2015-004898-32-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd.1,012
已完成
不适用
Study on mortality of asthmatic patients with airflow obstruction based on cohort of air pollution-related respiratory diseases in Omuta cityasthmaJPRN-UMIN000031509Kurume University697
进行中（未招募）
不适用
Pilot study on asthma control in patients with grass- pollen allergic rhinitis treated with 5 grass-pollen sublingual immunotherapy (Staloral®) vs placeboRespiratory Allergy: Asthma and allergic rhinitis due to grass pollenEUCTR2014-003204-70-ESDr. Javier Domínguez Ortega
进行中（未招募）
1 期
Observational study in allergic patients to treating hay fever against grass pollen.Patient reported outcome in patients treated with various doses of Depigoid Phleum.Allergic rhinitis/rhinoconjunctivitis with or without concomitant asthma due to grass pollen allergyMedDRA version: 14.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853MedDRA version: 14.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855MedDRA version: 14.1Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855EUCTR2013-004920-12-CZETI Pharma GmbH275